Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

RGNX

REGENXBIO Inc.

CIK 0001590877 · Nasdaq

NasdaqHealth CareBiological Products, (No Diagnostic Substances)
$15.65
↑ 0.42 (2.76%)
as of Jul 9, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: BullishOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership, Technicals, Options; Risks: Fundamentals

Key stats

Market Cap
$809.07M
P/E Ratio
-2.79
EPS
-3.76
Dividend Yield
Not covered
52W Position
95%
Beta
2.14

Valuation multiples

Fwd P/E
Not covered
PEG
0.26
P/B
38.38
P/S
9.21
EV/Revenue
9.04
ROE
-1375.6%
Valuation data covers 8,503/9,463 US-listed stocks (89.9%).

Price · 1Y

250 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 95%
$5.46$16.19

Latest Financials

2025-12-31 FY
Revenue
$170.44M
Net Income
-$193.88M
Total Assets
$453.03M
Free Cash Flow
-$126.38M

Recent news